Back to Search
Start Over
Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy.
- Source :
- Journal of Nuclear Medicine; Jul2014, Vol. 55 Issue 7, p1047-1053, 7p, 2 Color Photographs, 3 Charts, 2 Graphs
- Publication Year :
- 2014
Details
- Language :
- English
- ISSN :
- 01615505
- Volume :
- 55
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Journal of Nuclear Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 96993536
- Full Text :
- https://doi.org/10.2967/jnumed.113.136044